Regeneron, Sanofi Eczema Drug Clears Hurdles in Big TrialsRegeneron, Sanofi Eczema Drug Clears Hurdles in Big Trials

Regeneron Pharmaceuticals Inc and Sanofi said on Friday their experimental treatment for eczema proved highly effective in two large studies, without serious side effects often seen with standard treatments for the chronic inflammatory skin disease. Reuters Health Information

Source: Medscape Dermatology Headlines - April 4, 2016 Category: Dermatology Tags: Dermatology News Source Type: news